NCT06238193Completed
Molecular Characteristics of Early-onset Compared With Late-onset Colorectal Cancer
Source: ClinicalTrials.gov · Last updated 2 Feb 2024
Brief summary (registry, in English)
The distribution rate of microsatellite instability-high (MSI-H) was significantly higher in early-onset colorectal cancer, and early-onset colorectal cancer has a specific mutational profile and relatively high programmed cell death ligand 1(PD-L1) expression, which may be used to guide personalized treatment to better control the disease.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 11344 (actual)
- First submitted
- 22 Jan 2024
- Start date
- 1 Jan 2003
- Primary completion date
- 31 Dec 2022
- Lead sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Diseases
- Colorectal cancer
- NCT number
- NCT06238193
What you commit to
- Study type: Observational
- Participants enrolled: 11344
- From 1 Jan 2003 to the primary completion date, 31 Dec 2022
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Recurrent colorectal cancer;
Age
- Patients over 80 years of age;
Other
- Multiple primary tumors.
Who the study is looking for
- Men and women aged 18-75 years old;
- Histologically proven colon or rectal adenocarcinoma.
Age in the registry: 18 years to 80 years · Sex: All
This page is information, not medical advice. Discuss any trial with your doctor.